facebook

twitter

youtube

linkedin

Home - News and Events - News - The Hidden Costs of Rare Diseases, a feasibility study

December 01 2016

The Hidden Costs of Rare Diseases, a feasibility study

SHARE

Genetik Alliance UK has conducted a study on the hidden costs of Rare Diseases, assessing how best to measure and evaluate the true costs of managing rare conditions.

More info here

Read the full report here

ERN Monitoring Report 2025 Key findings

27 November 2025

European Commission Publishes First Monitoring Report on the European Reference Networks

RDD_2026_FB_banners_template

20 November 2025

100 Days to Rare Disease Day 2026

Applications Closed Announcement Landscape

17 November 2025

Applications Close for the VASCERN Summer School 2026

ERDERA-workshop-1-768x543

31 October 2025

ERDERA to launch the 2026 Joint Transnational Call on rare diseases

Miikka and Caroline WODC 2025

30 October 2025

Prof. Miikka Vikkula Shares Insights at the World Orphan Drug Congress 2025

29 October 2025

New Toolkit on Communication in Rare Diseases

01cd6db2-d0bd-496f-bb9b-0bb4f5387930

28 October 2025

VASCERN’s Lymphoedema Colouring Book Gains International Recognition

24 October 2025

Marfan Europe Network: Advancing Collaboration Across Europe

Group Photo VASCERN Days 2025

22 October 2025

Highlights from VASCERN Days 2025 in Paris